+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140343
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione is shaping industry agendas by bridging advanced therapeutic innovation and responsive animal health management. Senior executives are reevaluating strategies as sustainability and regulatory shifts realign growth opportunities and reshape competitive advantage in this specialty chemical segment.

Market Snapshot: 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione

The global market for 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione demonstrates strong momentum, driven by pharmaceutical R&D innovation and the expanding use of the compound in veterinary and animal health applications. Factors such as regulatory emphasis on green synthesis, rising public-private partnerships, and growing demand for both precision medicine and sustainable practices are accelerating market transformation. Key players are consolidating to leverage advanced processing methods and localize production to strengthen resilience against trade uncertainties. This market is further characterized by diversification in distribution channels, robust collaboration across academia and industry, and a shift toward environmentally conscious sourcing models.

Scope & Segmentation

  • Applications: Animal healthcare (equine medicine, small animal health); pharmaceutical (cardiovascular and respiratory disorders, including coronary heart disease, peripheral vascular disease, asthma, bronchitis, and COPD).
  • Distribution Channels: Direct tender (government, private), hospital pharmacies (private, public), online pharmacies (e-pharmacy platforms, manufacturer direct sales), retail pharmacies (chain, independent).
  • Product Types: Natural production (microbial fermentation via bacterial or fungal processes; plant extraction through solvent or supercritical fluid extraction), synthetic production (chemical and green synthesis).
  • End Users: Clinics (outpatient, specialty), home care settings (home healthcare providers, self-medication), hospitals (private, public).
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—including leading and emerging subregions.
  • Technologies: High-throughput screening, advanced computational modeling, microbial and plant-based green synthesis, supercritical extraction, and digital R&D optimization.

Key Takeaways for Senior Decision-Makers

  • Unique molecular design of 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione increases bioavailability and receptor specificity, supporting innovative therapeutic solutions and advanced animal health products.
  • Recent advances in lead optimization and precision chemistry, enabled by modern screening platforms, are reducing R&D cycle time and enabling agile cross-functional collaboration.
  • Green synthesis, microbial fermentation, and plant-based extraction methods are displacing traditional manufacturing, aligning with sustainability targets and enhancing cost efficiency.
  • Demand for personalized medicine, especially in cardiovascular and respiratory care, is influencing formulation strategies and strengthening the case for tailored dosage forms.
  • Regional supply chain integration and strategic investments in eco-friendly production hubs are becoming paramount for resilience and growth, particularly in response to regulatory and tariff changes.
  • Competitive dynamics rewards companies with robust patent holdings, digital innovation capabilities, and strategic partnerships with contract manufacturing organizations.

Tariff Impact on Market Dynamics

Newly enforced U.S. tariffs on specialty chemical imports have introduced supply chain disruption and elevated acquisition costs for 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione. This has compelled manufacturers to investigate nearshoring, regional investments, and alternative precursor chemistries. Vertically integrated production and tariff engineering strategies are increasing in prevalence as organizations seek to mitigate volatility and maintain margin stability.

Research Methodology & Data Sources

This report blends primary research—interviews with executives, regulators, and academic experts—with secondary analysis from peer-reviewed literature, clinical trial registries, industry reports, and patent reviews. Analytical approaches include SWOT and PESTEL frameworks, with findings validated in expert workshops to ensure actionable, market-relevant insights.

Why This Report Matters

  • Equip leadership teams with a comprehensive overview of evolving regulatory, technological, and supply chain landscapes in the 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione market.
  • Highlight strategic opportunities through in-depth segmentation, regional analysis, and coverage of key industry players and innovations.
  • Support data-driven planning using validated insights and actionable frameworks tailored for stakeholders seeking sustainable, competitive growth.

Conclusion

6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione is set to redefine both therapeutic and veterinary landscapes through a blend of innovation, sustainability, and strategic collaboration. Organizations prepared to adapt will capture lasting value in a dynamically evolving sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of novel continuous flow synthesis methods enhancing 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione yield and purity
5.2. Increasing adoption of green chemistry catalysts to reduce environmental footprint in large-scale 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione production
5.3. Regulatory momentum around advanced intermediates shaping quality control standards for 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione APIs
5.4. Strategic supplier consolidations aimed at securing raw material availability for 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione manufacturing
5.5. Integration of real-time analytics in process monitoring to optimize 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione reaction efficiency
5.6. R&D initiatives exploring novel therapeutic applications of 6-amino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione analogues in oncology and neurology
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market, by Application
8.1. Introduction
8.2. Animal Healthcare
8.2.1. Equine Medicine
8.2.2. Small Animal Health
8.3. Pharmaceutical
8.3.1. Cardiovascular Disorders
8.3.1.1. Coronary Heart Disease
8.3.1.2. Peripheral Vascular Disease
8.3.2. Respiratory Disorders
8.3.2.1. Asthma
8.3.2.2. Bronchitis
8.3.2.3. Copd
9. 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market, by Distribution Channel
9.1. Introduction
9.2. Direct Tender
9.2.1. Government Tenders
9.2.2. Private Tenders
9.3. Hospital Pharmacies
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Online Pharmacies
9.4.1. E Pharmacy Platforms
9.4.2. Manufacturer Direct Sales
9.5. Retail Pharmacies
9.5.1. Chain Pharmacies
9.5.2. Independent Pharmacies
10. 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market, by Product Type
10.1. Introduction
10.2. Natural
10.2.1. Microbial Fermentation
10.2.1.1. Bacterial Fermentation
10.2.1.2. Fungal Fermentation
10.2.2. Plant Extraction
10.2.2.1. Solvent Extraction
10.2.2.2. Supercritical Fluid Extraction
10.3. Synthetic
10.3.1. Chemical Synthesis
10.3.2. Green Synthesis
11. 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Outpatient Clinics
11.2.2. Specialty Clinics
11.3. Home Care Settings
11.3.1. Home Healthcare Providers
11.3.2. Self Medication
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Americas 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Lonza Group AG
15.3.3. Novasep SA
15.3.4. Cambrex Corporation
15.3.5. Evonik Industries AG
15.3.6. Merck KGaA
15.3.7. BASF SE
15.3.8. Siegfried Holding AG
15.3.9. Solvay S.A.
15.3.10. Wacker Chemie AG
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET: RESEARCHAI
FIGURE 24. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET: RESEARCHSTATISTICS
FIGURE 25. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET: RESEARCHCONTACTS
FIGURE 26. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY EQUINE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY EQUINE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SMALL ANIMAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SMALL ANIMAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CORONARY HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CORONARY HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COPD, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COPD, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY GOVERNMENT TENDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY GOVERNMENT TENDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE TENDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE TENDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY E PHARMACY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY E PHARMACY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY BACTERIAL FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY BACTERIAL FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY FUNGAL FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY FUNGAL FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SUPERCRITICAL FLUID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SUPERCRITICAL FLUID EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY GREEN SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY GREEN SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SELF MEDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SELF MEDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY MICROBIAL FERMENTATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PLANT EXTRACTION, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 214. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ANIMAL HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 215. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 216. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 217. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 218. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 219. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 220. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 221. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 224. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 225. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 234. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 235. CANADA 6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this 6-Amino-1,3-Dimethyl-1,2,3,4-Tetrahydropyrimidine-2,4-Dione Market report include:
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Novasep SA
  • Cambrex Corporation
  • Evonik Industries AG
  • Merck KGaA
  • BASF SE
  • Siegfried Holding AG
  • Solvay S.A.
  • Wacker Chemie AG